Researchers are evaluating the effects of adding atezolizumab to adjuvant treatment with trastuzumab emtansine in patients with HER2-positive breast cancer.
Patients with metastatic breast cancer who receive alpelisib in clinical practice have higher rates of hyperglycemia than patients who receive the drug in clinical trials, a new study suggests.
Researchers are conducting a phase 3 trial to compare Dato-DXd, with or without durvalumab, to investigator’s choice of treatment in patients with TNBC.
Privately-insured cancer patients living in states with restrictive telehealth policies were less likely to use telehealth in 2020 and 2021, a study showed.